DENTSPLY SIRONA’s (XRAY) Hold Rating Reiterated at Needham & Company LLC

Needham & Company LLC reaffirmed their hold rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a research report sent to investors on Monday,Benzinga reports.

A number of other research firms have also weighed in on XRAY. Piper Sandler reduced their target price on DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a report on Wednesday, April 30th. UBS Group decreased their price target on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating on the stock in a research note on Friday, May 9th. Barrington Research upped their price objective on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Monday, May 12th. Wall Street Zen raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Sunday, July 13th. Finally, Morgan Stanley lowered shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price target for the company. in a report on Tuesday, April 15th. Ten research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $19.60.

DENTSPLY SIRONA Stock Up 2.7%

DENTSPLY SIRONA stock opened at $16.85 on Monday. DENTSPLY SIRONA has a fifty-two week low of $12.16 and a fifty-two week high of $27.95. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.76 and a current ratio of 1.10. The firm’s 50-day simple moving average is $16.05 and its 200 day simple moving average is $16.24. The stock has a market cap of $3.36 billion, a PE ratio of -3.71, a price-to-earnings-growth ratio of 1.17 and a beta of 0.94.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating the consensus estimate of $0.29 by $0.14. The business had revenue of $879.00 million for the quarter, compared to the consensus estimate of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 14.31% and a negative net margin of 24.42%. DENTSPLY SIRONA’s revenue for the quarter was down 7.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.42 earnings per share. Research analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, July 11th. Shareholders of record on Friday, June 27th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, June 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.80%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.10%.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently bought and sold shares of XRAY. Mirae Asset Global Investments Co. Ltd. bought a new position in DENTSPLY SIRONA in the 1st quarter worth about $25,000. Colonial Trust Co SC bought a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at $26,000. Brooklyn Investment Group bought a new position in shares of DENTSPLY SIRONA during the first quarter valued at $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of DENTSPLY SIRONA in the first quarter worth approximately $26,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock valued at $33,000 after acquiring an additional 1,568 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.